Table 4 Histological risk factors of the patients and the adjuvant therapy received (no. of surgery = 72).
Variable | n(%) | Median (range) |
|---|---|---|
Tumor size, mm | 25(0–40) | |
Pelvic lymph nodes | 18(10–31) | |
Para-aortic lymph nodes | 6(4–18) | |
Lymph node positivity, n(%) | 13(18.1%) | |
Lymphovascular space invasion, n(%) | 13(18.0%) | |
Deep stromal invasion, n(%) | 37(51.4%) | |
Parametrial width, cm | 2(1–4) | |
Positive parametrial margins, n(%) | 1(1.4%) | |
Positive vaginal margins, n(%) | 0(0%) | |
Adjuvant treatment, n(%) | ||
Radiotherapy | 11(15.2%) | |
Concurrent chemoradiotherapy | 28(38.8%) | |
Chemotherapy | 3(4.1%) | |
Recurrence, n(%) | 5(6.9%) | |
Site of recurrencea, n(%) | ||
Local | 1(1.4%) | |
Regional | 2(2.8) | |
Distant | 3(4.1%) | |
Death of disease, n(%) | 1(1.4%) | |
